BioLife Solutions (BLFS) said Monday it has acquired $2 million of convertible notes in biotechnology company Pluristyx as part of a larger financing round.
BioLife also said it signed a separate agreement with Pluristyx that gives it a board observer seat and provides it with certain rights relating to a potential future acquisition of Pluristyx.